The SUSTAIN-6 trial demonstrated a 26% reduction in heart attack, stroke and heart related deaths in adults with type 2 diabetes and coronary artery disease or multiple heart risk factors
A comprehensive lipid panel should always consider both, along with HDL, to understand true cardiovascular and metabolic risk
Further, the percentage of participants achieving a weight reduction of 5% or more was higher in the tirzepatide groups (85%, 89%, and 91% at 5mg, 10mg, and 15mg, respectively) compared to placebo (35%) [8]
Most protocols involve subcutaneous injections 5-7 times per week, typically before bed to align with natural GH secretion patterns
Molecular Signalling Investigations Laboratory research may evaluate: Intracellular signalling cascades Hormonal receptor analogue modelling Transcription pathway activation Metabolic signalling interactions 3
Acquired conditions and genetic factors have been implicated in IR